BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32334637)

  • 1. Telemedicine strategy of the European Reference Network ITHACA for the diagnosis and management of patients with rare developmental disorders.
    Smith M; Alexander E; Marcinkute R; Dan D; Rawson M; Banka S; Gavin J; Mina H; Hennessy C; Riccardi F; Radio FC; Havlovicova M; Cassina M; Emandi AC; Fradin M; Gompertz L; Nordgren A; Traberg R; Rossi M; Trimouille A; Sowmyalakshmi R; Dallapiccola B; Renieri A; Faivre L; Kerr B; Verloes A; Clayton-Smith J; Douzgou S;
    Orphanet J Rare Dis; 2020 Apr; 15(1):103. PubMed ID: 32334637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital health and Clinical Patient Management System (CPMS) platform utility for data sharing of neuromuscular patients: the Italian EURO-NMD experience.
    Fortunato F; Bianchi F; Ricci G; Torri F; Gualandi F; Neri M; Farnè M; Giannini F; Malandrini A; Volpi N; Lopergolo D; Silani V; Ticozzi N; Verde F; Pareyson D; Fenu S; Bonanno S; Nigro V; Peduto C; D'Ambrosio P; Zeuli R; Zanobio M; Picillo E; Servidei S; Primiano G; Sancricca C; Sciacco M; Brusa R; Filosto M; Cotti Piccinelli S; Pegoraro E; Mongini T; Solero L; Gadaleta G; Brusa C; Minetti C; Bruno C; Panicucci C; Sansone VA; Lunetta C; Zanolini A; Toscano A; Pugliese A; Nicocia G; Bertini E; Catteruccia M; Diodato D; Atalaia A; Evangelista T; Siciliano G; Ferlini A
    Orphanet J Rare Dis; 2023 Jul; 18(1):196. PubMed ID: 37480080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CPMS-improving patient care in Europe via virtual case discussions.
    Mönig I; Steenvoorden D; de Graaf JP; Ahmed SF; Taruscio D; Beun JG; Johannsen TH; Juul A; Hiort O; Pereira AM
    Endocrine; 2021 Mar; 71(3):549-554. PubMed ID: 33528763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERN BOND: The key European network leveraging diagnosis, research, and treatment for rare bone conditions.
    Casareto L; Appelman-Dijkstra NM; Brandi ML; Chapurlat R; Cormier-Daire V; Hamdy NAT; Heath KE; Horn J; Mantovani G; Mohnike K; Sousa SB; Travessa A; Wekre LL; Zillikens MC; Sangiorgi L;
    Eur J Med Genet; 2024 Apr; 68():104916. PubMed ID: 38296035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical evaluation of the EU-virtual consultation platform (CPMS) within the European Reference Network on Rare Endocrine Conditions.
    White EK; Wagner IV; van Beuzekom C; Iotova V; Ahmed SF; Hiort O; Pereira AM
    Endocr Connect; 2022 Nov; 11(11):. PubMed ID: 36112499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [European Reference Network for Rare Hepatological Diseases (ERN RARE-LIVER)].
    Schulz L; Sebode M; Schramm C; Lohse AW
    Internist (Berl); 2021 Apr; 62(4):441-448. PubMed ID: 33687527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Child-to-adult transition: a survey of current practices within the European Reference Network for Rare Neurological Diseases (ERN-RND).
    Nanetti L; Kearney M; Boesch S; Stovickova L; Ortigoza-Escobar JD; Macaya A; Gomez-Andres D; Roze E; Molnar MJ; Wolf NI; Darling A; Vasco G; Bertini E; Indelicato E; Neubauer D; Haack TB; Sagi JC; Danti FR; Sival D; Zanni G; Kolk A; Boespflug-Tanguy O; Schols L; van de Warrenburg B; Vidailhet M; Willemsen MA; Buizer AI; Orzes E; Ripp S; Reinhard C; Moroni I; Mariotti C;
    Neurol Sci; 2024 Mar; 45(3):1007-1016. PubMed ID: 37853291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER.
    Bernts LHP; Jones DEJ; Kaatee MM; Lohse AW; Schramm C; Sturm E; Drenth JPH
    Orphanet J Rare Dis; 2019 Jul; 14(1):169. PubMed ID: 31287000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The European Reference Network for Rare Neurological Diseases.
    Reinhard C; Bachoud-Lévi AC; Bäumer T; Bertini E; Brunelle A; Buizer AI; Federico A; Gasser T; Groeschel S; Hermanns S; Klockgether T; Krägeloh-Mann I; Landwehrmeyer GB; Leber I; Macaya A; Mariotti C; Meissner WG; Molnar MJ; Nonnekes J; Ortigoza Escobar JD; Pérez Dueñas B; Renna Linton L; Schöls L; Schuele R; Tijssen MAJ; Vandenberghe R; Volkmer A; Wolf NI; Graessner H
    Front Neurol; 2020; 11():616569. PubMed ID: 33519696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
    Parker S
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases.
    Zurek B; Ellwanger K; Vissers LELM; Schüle R; Synofzik M; Töpf A; de Voer RM; Laurie S; Matalonga L; Gilissen C; Ossowski S; 't Hoen PAC; Vitobello A; Schulze-Hentrich JM; Riess O; Brunner HG; Brookes AJ; Rath A; Bonne G; Gumus G; Verloes A; Hoogerbrugge N; Evangelista T; Harmuth T; Swertz M; Spalding D; Hoischen A; Beltran S; Graessner H;
    Eur J Hum Genet; 2021 Sep; 29(9):1325-1331. PubMed ID: 34075208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Healthcare networks for people with rare diseases: integrating data and expertise].
    Graessner H; Storf H; Schaefer F
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Nov; 65(11):1164-1169. PubMed ID: 36167994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET.
    Talarico R; Aguilera S; Alexander T; Amoura Z; Andersen J; Arnaud L; Avcin T; Marsal Barril S; Beretta L; Bombardieri S; Bortoluzzi A; Bouillot C; Bulina I; Burmester GR; Cannizzo S; Cavagna L; Chaigne B; Cornet A; Corti P; Costedoat-Chalumeau N; Dāvidsone Z; Doria A; Fenech C; Ferraris A; Fischer-Betz R; Fonseca JE; Frank C; Gaglioti A; Galetti I; Guimarães V; Hachulla E; Holmner M; Houssiau F; Iaccarino L; Jacobsen S; Limper M; Malfait F; Mariette X; Marinello D; Martin T; Matthews L; Matucci-Cerinic M; Meyer A; Milas-Ahić J; Moinzadeh P; Montecucco C; Mouthon L; Müller-Ladner U; Nagy G; Patarata E; Pileckyte M; Pruunsild C; Rednic S; Romão VC; Schneider M; Scirè CA; Smith V; Sulli A; Tamirou F; Tani C; Taruscio D; Taulaigo AV; Tincani A; Ticciati S; Turchetti G; van Hagen PM; van Laar JM; Viera A; de Vries-Bouwstra JK; Zschocke J; Cutolo M; Mosca M
    Clin Exp Rheumatol; 2022 May; 40 Suppl 134(5):3-11. PubMed ID: 35349419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centres of Expertise and European Reference Networks: key issues in the field of rare diseases. The EUCERD Recommendations.
    Taruscio D; Gentile AE; Evangelista T; Frazzica RG; Bushby K; Montserrat AM
    Blood Transfus; 2014 Apr; 12 Suppl 3(Suppl 3):s621-5. PubMed ID: 24922304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RarERN Path: a methodology towards the optimisation of patients' care pathways in rare and complex diseases developed within the European Reference Networks.
    Talarico R; Cannizzo S; Lorenzoni V; Marinello D; Palla I; Pirri S; Ticciati S; Trieste L; Triulzi I; Terol E; Bucher A; Turchetti G
    Orphanet J Rare Dis; 2020 Dec; 15(1):347. PubMed ID: 33317578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of EXABO - An Expert Advisory Board for the European Reference Network for Rare Respiratory Diseases.
    Walther D; Steinmann O; Wagner TOF; Storf H
    Stud Health Technol Inform; 2020 Jun; 270():986-990. PubMed ID: 32570529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspective.
    Mañú Pereira MDM; Colombatti R; Alvarez F; Bartolucci P; Bento C; Brunetta AL; Cela E; Christou S; Collado A; de Montalembert M; Dedeken L; Fenaux P; Galacteros F; Glenthøj A; Gutiérrez Valle V; Kattamis A; Kunz J; Lobitz S; McMahon C; Pellegrini M; Reidel S; Russo G; Santos Freire M; van Beers E; Kountouris P; Gulbis B
    Lancet Haematol; 2023 Aug; 10(8):e687-e694. PubMed ID: 37451300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The need for widely available genomic testing in rare eye diseases: an ERN-EYE position statement.
    Black GC; Sergouniotis P; Sodi A; Leroy BP; Van Cauwenbergh C; Liskova P; Grønskov K; Klett A; Kohl S; Taurina G; Sukys M; Haer-Wigman L; Nowomiejska K; Marques JP; Leroux D; Cremers FPM; De Baere E; Dollfus H;
    Orphanet J Rare Dis; 2021 Mar; 16(1):142. PubMed ID: 33743793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards FAIRification of sensitive and fragmented rare disease patient data: challenges and solutions in European reference network registries.
    Dos Santos Vieira B; Bernabé CH; Zhang S; Abaza H; Benis N; Cámara A; Cornet R; Le Cornec CMA; 't Hoen PAC; Schaefer F; van der Velde KJ; Swertz MA; Wilkinson MD; Jacobsen A; Roos M
    Orphanet J Rare Dis; 2022 Dec; 17(1):436. PubMed ID: 36517834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-constructing effective collective intelligence networks in rare diseases: a mixed method approach to identify the parameters that matter for patients, professionals and policy-makers, piloted in Cyprus.
    Antoniadou V; Hadjipanayis A
    Orphanet J Rare Dis; 2023 Apr; 18(1):97. PubMed ID: 37118739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.